From Dysbiosis to Detection: Exploring the Impact of Vaginal Microbiome Testing on Reproductive... @Labroots
From Dysbiosis to Detection: Exploring the Impact of Vaginal Microbiome Testing on Reproductive...  @Labroots
Uploaded December 2025 | Updated November 2026, 2 days ago
Presented By: Dr. Arne Materna

Speaker Biography: He joined Bio-Me as Chief Technology Officer in 2023 and was appointed Co-CEO on July 1, 2024. In addition to his leadership role, Dr. Materna serves as a member of Bio-Me’s Board of Directors. A recognized expert in the development and commercialization of market-leading assay and BioIT technologies for microbiome and infectious disease applications, Dr. Materna brings a proven track record of impactful contributions. He has held senior management and executive roles at leading life sciences companies, including CLC bio, QIAGEN, CosmosID, and Ares Genetics.Dr. Materna earned his PhD in molecular biology from the University of Konstanz, Germany, and further specialized in microbial genomics and microbiome research as a postdoctoral fellow and leader of an experimental research laboratory at the Massachusetts Institute of Technology (MIT).

Webinar: From Dysbiosis to Detection: Exploring the Impact of Vaginal Microbiome Testing on Reproductive Success

Webinar Abstract: Infertility affects one in six couples, with fertility treatments facing daunting 2:1 odds of failure versus success. Emerging research highlights the critical role of vaginal microbiome health in reproductive outcomes. Dysbiosis and other microbiological conditions of the female genitourinary system have been strongly linked to poor fertility outcomes. However, routine infertility care is hindered by the lack of standardized diagnostic tools for microbiome characterization. Current standard of care tests are not suitable for microbiome profiling, and common approaches for microbiome analysis, such as sequencing, face significant technical limitations when applied to vaginal specimens.
This presentation reviews key studies connecting vaginal microbiome health to fertility outcomes and examines the technical barriers to vaginal microbiome analysis. It introduces PMP™, a precision microbiome profiling method utilizing highly parallelized single-plex quantitative PCR, and discusses its potential for routine use in infertility care, including applications in blended care models.

Labroots on Social:
Facebook: facebook.com/LabRootsInc
Twitter: twitter.com/LabRoots
LinkedIn: linkedin.com/company/labroots
Instagram: instagram.com/labrootsinc
Pinterest: pinterest.com/labroots
SnapChat: labroots_inc
From Dysbiosis to Detection: Exploring the Impact of Vaginal Microbiome Testing on Reproductive...(Sybille Langenecker, MD, MBA) Navigating Bleeding Management Guidelines from Global Regions:...Defining plasma proteomic biomarkers features of response and resistance to immune checkpoint...Effect of fecal microbiota transplantation on immune tonusUnveiling COSMICs secrets: Curating gene and somatic variant data to power research and clinical...Beyond PCR: Unlocking the potential of RCA and RPA isothermal amplification methods(Jacob Raphael, MD, FAHA) Navigating Bleeding Management Guidelines from Global Regions...Advances in PSC Workflows to Build Better Models and TherapiesAnything but oxygen - Considerations for anaerobic and microaerophilic bacteria cultureLessons learned in analytical chemistry from developing an accredited microplastics labTrack keynote: Broad-capture proteomics to improve rare disease diagnosis and characterizationSafeguard dataset quality in LC-MS analysis with system suitability testing and intelligent run...
Labroots |

From Dysbiosis to Detection: Exploring the Impact of Vaginal Microbiome Testing on Reproductive...

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER